Category: Private Citizen — Corporate Executive Director Role: Non-Executive Board Chair, UnitedHealth Group Inc. (UNH) Board Tenure: 2000 – present; Board Chair since 2019 Committee Memberships: None (Board Chair capacity) Profile Type: Board Member Accountability — Anchor B (Documented Organizational Leadership)

Basis for Inclusion: Stephen Hemsley holds the highest governance oversight role at UnitedHealth Group as its non-executive Board Chair. Having served as UnitedHealth’s CEO from 2006 to 2017 and as its President and COO before that, Hemsley possesses deeper institutional knowledge of UnitedHealth’s strategic direction, political relationships, and business practices than any other board member. As Board Chair, he presides over the board that oversees the CEO’s political engagement strategy and the corporate decisions documented in the parent corporate donor profile. This profile documents the factual governance relationship, not the subject’s personal political views.

Subject Classification: Private Citizen / Corporate Executive Director. Board membership and executive history are matters of public record (SEC filings, proxy statements). This profile documents only the governance role and its connection to documented corporate political activity.

Biographical Overview

Stephen J. Hemsley has been deeply embedded in UnitedHealth Group’s growth from a $26 billion to a $320+ billion revenue company. He joined the company in 1997 as CFO and was named President and COO in 1999, then CEO in 2006. During his CEO tenure (2006–2017), UnitedHealth became the largest health insurer in the United States and one of the largest companies in the world, growing through both organic expansion and major acquisitions including OptumRx (pharmacy benefits), Optum Health (care delivery), and Change Healthcare.

Hemsley stepped down as CEO in 2017 after a 20-year operating run and became non-executive Board Chair in 2019. His compensation during his CEO tenure included controversial stock option grants; he repaid approximately $190 million in stock options backdating-related settlement in 2009. He remains the most influential individual in UnitedHealth’s governance structure due to his deep familiarity with the company’s operations, competitive strategy, and political relationships.

He holds a B.A. in Economics and an MBA from the University of Minnesota.

Board Role and Governance Authority

• Company: UnitedHealth Group Inc. (NYSE: UNH)
• Board tenure: 2000 – present; Chair since 2019
• Executive history: CEO (2006–2017), President & COO (1999–2006), CFO (1997–1999)

Parent Corporate Donor Profile

This profile is a governance-accountability companion to the UnitedHealth Group corporate donor profile, which documents the corporation’s political spending and regulatory relationships under the Trump administration.

Factual correction requests: If you believe information in this profile is incorrect, please contact factcheck@patriot.university with your name (optional), the specific claim, and any supporting documentation. We review all submissions and correct verified errors promptly.

Investigative trail pointers (public records)

Education only — verify independently. Absence of hits is not proof.

Use public-records-research-specialist, corporate-intelligence-investigator, and public-corruption-ombudsman evidence tiers.

Sources

• UnitedHealth Group Inc. DEF 14A Proxy Statement, filed April 21, 2025; SEC EDGAR (CIK 731766)